Veritable, L.P. Bristol Myers Squibb CO Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $3.19 Million - $3.54 Million	49,997 Added 63.16%	129,154 $8.26 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $392,551 - $445,242	5,974 Added 8.16%	79,157 $5.49 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $102,651 - $121,553	1,499 Added 2.09%	73,183 $5.26 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $5,637 - $3.33 Million	-43,363 Reduced 37.69%	71,684 $5.1 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $522,210 - $575,136	7,191 Added 6.67%	115,047 $8.86 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $64,246 - $77,037	1,045 Added 0.98%	107,856 $7.88 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $34,859 - $40,638	650 Added 0.61%	106,811 $6.66 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $28,934 - $33,892	-489 Reduced 0.46%	106,161 $6.28 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $67,296 - $73,285	1,087 Added 1.03%	106,650 $7.13 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $1.82 Million - $2.05 Million	-30,726 Reduced 22.54%	105,563 $6.66 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $6.66 Million - $7.54 Million	-115,288 Reduced 45.83%	136,289 $8.45 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $51,572 - $57,148	898 Added 0.36%	251,577 $15.2 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $519,474 - $607,316	-9,476 Reduced 3.64%	250,679 $14.7 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $2.2 Million - $3.2 Million	47,395 Added 22.28%	260,155 $14.5 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $1.84 Million - $2.4 Million	37,383 Added 21.32%	212,760 $13.7 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $125,059 - $148,276	2,924 Added 1.7%	175,377 $8.89 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $59,389 - $65,671	-1,331 Reduced 0.77%	172,453 $7.82 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $40,878 - $48,742	906 Added 0.52%	173,784 $8.29 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2.72 Million - $3.52 Million	-55,743 Reduced 24.38%	172,878 $8.99 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $164,797 - $185,878	2,986 Added 1.32%	228,621 $14.2 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $180,543 - $225,027	-3,573 Reduced 1.56%	225,635 $12.5 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $217,509 - $250,397	-3,630 Reduced 1.56%	229,208 $14.5 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $1.69 Million - $1.84 Million	-28,130 Reduced 10.78%	232,838 $14.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $14.4 Million - $16.6 Million	260,968	260,968 $16.6 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.15 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.36 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.52 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account